BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21730011)

  • 1. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
    Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB; McMahon LR
    Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
    Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
    Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
    Cunningham CS; Javors MA; McMahon LR
    J Pharmacol Exp Ther; 2012 Jun; 341(3):840-9. PubMed ID: 22438471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
    Cunningham CS; McMahon LR
    Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic aspects of the discriminative stimulus effects of arecoline.
    Winger G
    Behav Pharmacol; 2021 Oct; 32(7):581-589. PubMed ID: 34417356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW; Mogg A; Tafi E; Peacey E; Pullar IA; Szekeres P; Tricklebank M
    Psychopharmacology (Berl); 2007 Feb; 190(2):157-70. PubMed ID: 17115136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.
    Desai RI; Bergman J
    J Pharmacol Exp Ther; 2010 Dec; 335(3):807-16. PubMed ID: 20847037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
    Gould RW; Czoty PW; Nader SH; Nader MA
    J Pharmacol Exp Ther; 2011 Nov; 339(2):678-86. PubMed ID: 21856860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine-like discriminative and aversive effects of two α4β2-selective nicotine agonists, ispronicline and metanicotine.
    Winger G
    Behav Pharmacol; 2021 Sep; 32(6):497-504. PubMed ID: 34320519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of the nicotinic agonist cytisine.
    Chandler CJ; Stolerman IP
    Psychopharmacology (Berl); 1997 Feb; 129(3):257-64. PubMed ID: 9084064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.
    Mohler EG; Franklin SR; Rueter LE
    Psychopharmacology (Berl); 2014 Jan; 231(1):67-74. PubMed ID: 23925734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine (DHbetaE) in rats.
    Shoaib M; Zubaran C; Stolerman IP
    Psychopharmacology (Berl); 2000 Apr; 149(2):140-6. PubMed ID: 10805608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminative stimulus effects of epibatidine in C57BL/6J mice.
    de Moura FB; Hiranita T; McMahon LR
    Behav Pharmacol; 2020 Sep; 31(6):565-573. PubMed ID: 32209809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC; O'Neill HC; Marks MJ; Grady SR
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine and bupropion share a similar discriminative stimulus effect.
    Young R; Glennon RA
    Eur J Pharmacol; 2002 May; 443(1-3):113-8. PubMed ID: 12044800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.